Results 131 to 140 of about 46,386 (217)

One-Month Rifapentine-Isoniazid Regimen Versus Six-Month Isoniazid Monotherapy for Latent Tuberculosis: Experience from a Reference Center. [PDF]

Medicina (Kaunas)
Simões JM, Ferreira D, Mourato T, Pais A, Dias A, Torres M, Coelho L.   +6 more
europepmc   +1 more source

Tuberculosis Prevention in Pregnant Women Living with HIV: A Review of the Current Management Strategies and Guidance. [PDF]

Infect Drug Resist
Darveau SC, Yadav S, Dooley KE, Mathad JS.   +3 more
europepmc   +1 more source

Rapid drug susceptibility testing of Mycobacterium tuberculosis against first-line drugs simultaneously all-in-one plate by using a novel high-sensitive reporter phage combined with the BACTEC MGIT 960 system. [PDF]

Infect Dis Poverty
Ma R, Zhang Y, Zhu M, Zhang M, Qian C, Wu J, Hu Z, Guo M, Fan XY.   +8 more
europepmc   +1 more source

Rifapentine-isoniazid versus isoniazid-alone therapy for tuberculosis prevention among people living with HIV (PLHIV): a systematic review and meta-analysis of randomized trials. [PDF]

BMC Infect Dis
Ahmed SH, Hassan SS, Qadar LT, Selsky N, Duharte M, Hegazi M, Shaik AA, Asghar MS.   +7 more
europepmc   +1 more source

Tuberculosis preventive therapy in Sierra Leone: early implementation gaps and lessons learned. [PDF]

Public Health Action
Farma-Grant L, Kanu JS, Molleh B, Kamara IF, Kamara ARY, Sesay N, Lahai WK, Fofanah B, Falama MA, Offe Amponsah OK, Mahmoud M, Grant DS, Siatty Y, Zachariah R, Koroma J, Mustapha M, Sesay T, Kenneh S.   +17 more
europepmc   +1 more source

Programmatic impact and cost-effectiveness of scaling up the short-course 3HP regimen for tuberculosis preventive treatment in Brazil. [PDF]

BMJ Glob Health
Villalva-Serra K, Barreto-Duarte B, Rodrigues MM, Queiroz ATL, Croda J, Rolla VC, Kritski AL, Sterling TR, Cordeiro-Santos M, Araújo-Pereira M, Andrade BB.   +10 more
europepmc   +1 more source

Landouzy sepsis in a young adult with multiorgan failure: successful ECMO-assisted management using an individualized antituberculous regimen. [PDF]

BMC Infect Dis
van de Sand L, Dubler S, Bertram S, Aulenkamp JL, Pirschtat NV, Witzke O, Hegerfeldt Y, Zettler M.   +7 more
europepmc   +1 more source

Characterizing isoniazid preventive therapy uptake among people living with human immunodeficiency virus in Tanzania, a resource-constrained setting with a high tuberculosis burden: A systematic review and meta-analysis. [PDF]

IJID Reg
Sindato EM, Kajogoo VD, Mchonde GJ, Mpondo BCT.   +3 more
europepmc   +1 more source

Analysis of the impact of national centralized volume-based procurement drug policy on the market dynamics of tuberculosis drugs. [PDF]

BMC Health Serv Res
Yang J, Yu X, Yao Y, Zhao W, Chen Y, Wang Z, Xu M.   +6 more
europepmc   +1 more source